Tirofiban as treatment for acute retinal artery occlusion following internal carotid artery flow diverter implantation

    loading  Checking for direct PDF access through Ovid



To report a favorable outcome of branch retinal artery occlusion (BRAO) treated by means of early administration of tirofiban, a glycoprotein IIb-IIIa platelet receptor inhibitor.


Case report.


A 65-year-old woman developed dramatic visual impairment in her left eye secondary to BRAO after left internal carotid artery endovascular reconstruction with flow diverter stent implant; visual acuity was hand motion. A dose of intravenous tirofiban was injected 10 minutes after symptoms onset. Fourteen hours after drug infusion, retinal fluorescein angiography revealed a well-perfused macula with a partial reperfusion of the inferior temporal branch of the central retinal artery; visual acuity was 20/20 in both eyes.


This case supports the effectiveness of tirofiban in secondary BRAO in neurosurgery and may open its usage to further research.

Related Topics

    loading  Loading Related Articles